Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Boehringer Ingelheim

Status

Withdrawn

Conditions

Hypertension

Treatments

Drug: subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group

Drug: subjects treated with telmisartan/hydrochlorothiazide

Drug: subjects treated with telmisartan+amlodipine double pill

Drug: Subjects treated with Telmisartan and amlodipine

Study type

Observational

Funder types

Industry

Identifiers

NCT03205137

0502-0612

Details and patient eligibility

About

The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients with hypertension
Patients must have their first prescription (defined as index date*) for telmisartan and hydrochlorothiazide or Micombi® between 01/07/2010 and 28/09/2010
Patients must have their first prescription (defined as index date*) for telmisartan and amlodipine or Micamlo® between 10/12/2010 and 09/03/2011
Patients must have at least 180 days follow up verified by the presence of prescription record

Exclusion criteria

Patients who were under 40 years old at the time of enrolment
Patients who prescribed the study drugs less than 90 days during a follow up period of 180 days
Patients whose visits are less than 2 times during a follow up period of 180 days